Disease Information

Fanconi Anemia Explained

What Is FA?

FA is a genetic disease caused by mutations in any of the known 23 genes (including genes such as BRCA1 and BRCA2) that play a role in the FA DNA repair pathway. FA is considered a cancer-predisposition or cancer-susceptibility disease. Decades of research have revealed that faulty DNA repair causes FA, and individuals with FA are much more likely to develop cancer at a young age.

Learn More

Better Care Now

Clinical Care Guidelines

At Fanconi Cancer Foundation, we are in relentless pursuit of better care, better treatment, and ultimately, a cure for FA and FA-related cancers. Our clinical care guidelines are here as a resource for medical and care team providers who may never have crossed paths with FA before, in hopes they are able to provide better support for patients with FA.

Learn More

Knowledge Is Key

Cancer Awareness and Empowerment

Cancer can be daunting, and it’s natural to want to avoid dwelling on it. At FCF, we understand the weight of this concern for families affected by FA. That’s why we’re committed to partnering with the FA research and medical community to confront this challenge head-on. While experts work tirelessly towards solutions, we encourage you to stay informed without feeling overwhelmed.

Learn More

Stay Informed

Resource Library

Explore our library of educational materials and videos to empower individuals and families impacted by FA. Gain insights, guidance, and understanding to navigate FA’s complexities with more confidence.

Learn More

The Latest

News & Events

FCF and American Cancer Society Open 2026 Discovery Boost Grant for FA Cancer Research

We’re thrilled to announce a new partnership between the Fanconi Cancer Foundation (FCF) and the American Cancer Society (ACS): the Fanconi Cancer Foundation Discovery Boost Grant. This grant program will fuel innovative research aimed at preventing, detecting, and treating cancers associated with Fanconi anemia (FA).

Building the Evidence for Safer Cancer Care in FA

FCF has committed $631,164 to three projects addressing critical gaps in FA cancer research. The work spans different stages, from exploring oral gene therapy and screening drugs for FA-specific safety to analyzing clinical experiences that could inform future care. These projects are building the knowledge needed to pursue safer cancer options for people with FA.

New Mental Health and Wellbeing Toolkit Offers Practical Support for the FA Community

Living with Fanconi anemia, or caring for someone with FA, brings ongoing uncertainty, complex medical experiences and emotional strain. These experiences affect more than physical health. They can also shape mental health, relationships, daily routines and a person’s sense of safety and connection. The Fanconi Cancer Foundation is pleased to introduce the Mental Health and Wellbeing Toolkit, a new resource offering practical tools and trusted guidance for people living with FA and those who care for them.